Woo Yu Ri, Kim Hei Sung
Department of Dermatology, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.
J Clin Med. 2023 May 29;12(11):3744. doi: 10.3390/jcm12113744.
Atopic dermatitis (AD) is a chronic inflammatory skin condition associated with a significant disease burden in Korea. AD is highly prevalent among Korean children, adolescents, and adults, and can cause physical discomfort, psychological distress, and social isolation for those affected. Despite advances in our understanding of AD, there are still many unmet needs in diagnosing and managing the disease in Korea. One of the challenges in diagnosing AD is the lack of a definitive biomarker for AD in Korea, and there is a need for more effective, safe, and cost-effective treatments for AD. Therefore, finding out the current epidemiology, burden of AD, and how AD is currently being diagnosed in Korea and reviewing management options available in Korea will help resolve the unmet needs of AD patients in Korea. Addressing these and other unmet needs in AD management and diagnosis in Korea may improve outcomes for those affected by this challenging condition.
特应性皮炎(AD)是一种慢性炎症性皮肤病,在韩国造成了沉重的疾病负担。AD在韩国儿童、青少年和成年人中非常普遍,会给患者带来身体不适、心理困扰和社交孤立。尽管我们对AD的认识有所进步,但在韩国,AD的诊断和管理仍有许多未满足的需求。AD诊断面临的挑战之一是韩国缺乏AD的确诊生物标志物,并且需要更有效、安全且具成本效益的AD治疗方法。因此,了解韩国AD的当前流行病学、负担、当前的诊断方式以及审查韩国可用的管理选项,将有助于解决韩国AD患者未满足的需求。解决韩国AD管理和诊断中的这些及其他未满足需求,可能会改善受这一具有挑战性疾病影响者的治疗结果。